Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:785-789
doi: 10.1161/hy0302.105689
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyataka, M.
Right arrow Articles by Bing, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyataka, M.
Right arrow Articles by Bing, R. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETYLSALICYLIC ACID
*CELECOXIB
*NITRIC OXIDE
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Biochemistry and metabolism
Right arrow Growth factors/cytokines
Right arrow Endothelium/vascular type/nitric oxide

(Hypertension. 2002;39:785.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Nitric Oxide, Anti-Inflammatory Drugs on Renal Prostaglandins and Cyclooxygenase-2

Masaru Miyataka; Kathryn A. Rich; Marylou Ingram; Tadahiko Yamamoto; Richard J. Bing

From the Huntington Medical Research Institutes, Department of Experimental Cardiology (M.M., K.A.R., M.I., R.J.B.), Pasadena, Cal; and {dagger} Kinki University School of Medicine, First Department of Internal Medicine (T.Y.), Osaka, Japan.

Correspondence to Richard J. Bing, MD, Huntington Medical Research Institutes, 99 North El Molino Ave, Pasadena, CA 91101.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used as analgesics. They inhibit cyclooxygenases (COX), preventing the formation of prostaglandins, including prostacyclin and thromboxane. A serious side effect of COX-1 and COX-2 is renal damage. We report here that both a nonselective NSAID (aspirin, acetylsalicylic acid) and COX-2 selective NSAIDs (celecoxib and NS-398) diminished renal prostacyclin and thromboxane concentration in the renal medulla. NSAIDs failed to change COX-2 and iNOS (the inducible form of NO synthase) expression. A NO donor, B-NOD, preserved renal prostacyclin and thromboxane after administration of aspirin. PGI2 and COX-2 protein were mainly expressed in the renal medulla, whereas iNOS expression was greater in the cortex. B-NOD preserved renal prostacyclin levels after administration of NSAIDs.


Key Words: prostaglandins • kidney • aspirin • nitric oxide




This article has been cited by other articles:


Home page
CJASNHome page
R. C. Harris and M. D. Breyer
Update on Cyclooxygenase-2 Inhibitors
Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 236 - 245.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Wahn, J. Wolf, F. Kram, S. Frantz, and J. A. Wagner
The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2491 - H2496.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Bing
Reply
J. Am. Coll. Cardiol., August 7, 2002; 40(3): 578 - 578.
[Full Text] [PDF]